--Deere Raises Quarterly Dividend to $1.62 a Share From $1.47, Payable Feb. 10 to Holders of Record on Dec. 31-March 2024-www.financetom.com

--Deere Raises Quarterly Dividend to $1.62 a Share From $1.47, Payable Feb. 10 to Holders of Record on Dec. 31

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Deere Raises Quarterly Dividend to $1.62 a Share From $1.47, Payable Feb. 10 to Holders of Record on Dec. 31

Dec 3, 2024 12:50 PM

03:27 PM EST, 12/03/2024 (MT Newswires) --

Price: 461.32, Change: -1.63, Percent Change: -0.35

Previous page： TotalEnergies says it is examining cross-listing shares in U.S Next page： Cencora notifies individuals about cyberattack earlier this year, TechCrunch reports

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

TotalEnergies says it is examining cross-listing shares in U.S

May 24, 2024

PARIS (Reuters) - TotalEnergies said on Friday that it is studying plans to cross-list its shares in the United States, while also keeping its shares on the Euronext stock exchange. It's more a technical study, how to offer these shares to the American market, while keeping our shares on Euronext, in Paris, in London, in Brussels, because the majority of...

Cencora notifies individuals about cyberattack earlier this year, TechCrunch reports

May 24, 2024

May 24 (Reuters) - U.S. drug distributor Cencora ( COR ) has notified affected individuals that their personal and highly sensitive medical information was stolen during a cyberattack and data breach earlier this year, TechCrunch reported on Friday. ...

CG Oncology Says Potential Combination Therapy for Bladder Cancer Meets Phase 2 Primary Endpoint

May 24, 2024

09:58 AM EDT, 05/24/2024 (MT Newswires) -- CG Oncology ( CGON ) said Friday that its phase 2 trial of cretostimogene plus pembrolizumab to treat BCG-unresponsive high-risk non-muscle invasive bladder cancer with carcinoma in situ met its primary endpoint. Final data from the phase 2 trial showed a class-leading complete response and duration of response compared with existing and other...

KB Home Opens 2 New Communities in Las Vegas, California

May 24, 2024

09:53 AM EDT, 05/24/2024 (MT Newswires) -- KB Home ( KBH ) said Friday it has opened the Brevi community in Las Vegas, with pricing starting from the mid $400,000s. Separately, the homebuilder said it opened the Sedona community in Winchester, California. Pricing starts at the $540,000s, the company said. Shares of KBH were up 1.2% in recent Friday trading....